Showing results (111-120 of 151) with videos related to
Sort By:
Pageof 16
Plos One|September 26, 2017
High incidence of extensive chronic graft-versus-host disease in patients with the REG3A rs7588571 non-GG genotypeDaisuke Koyama, Makoto Murata, Ryo Hanajiri, et al.Cancer Science|May 29, 2012
Phase II study of dose-modified busulfan by real-time targeting in allogeneic hematopoietic stem cell transplantation for myeloid malignancyYachiyo Kuwatsuka, Akio Kohno, Seitaro Terakura, et al.International Journal of Hematology|February 16, 2017
Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell TransplantationAkio Shigematsu, Shinichi Kako, Kenjiro Mitsuhashi, et al.Plos One|May 9, 2014
Dexamethasone palmitate ameliorates macrophages-rich graft-versus-host disease by inhibiting macrophage functionsSatoshi Nishiwaki, Takayuki Nakayama, Makoto Murata, et al.Genes and Immunity|February 25, 2021
Donor UNC-93 Homolog B1 genetic polymorphism predicts survival outcomes after unrelated bone marrow transplantationKaori Uchino, Lam Vu Quang, Shohei Mizuno, et al.Oncotarget|May 10, 2017
Toll-like receptor genetic variations in bone marrow transplantationKaori Uchino, Shohei Mizuno, Aiko Sato-Otsubo, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 4, 2017
Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host DiseaseSaiko Kurosawa, Kumi Oshima, Takuhiro Yamaguchi, et al.International Journal of Hematology|February 24, 2012
Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II studyKensuke Usuki, Arinobu Tojo, Yasuhiro Maeda, et al.Medicine|February 1, 2018
Efficacy and safety of autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: A study protocol for a multicenter exploratory prospective study (Auto-Ph17 study)Satoshi Nishiwaki, Isamu Sugiura, Yasuhiko Miyata, et al.Blood|July 29, 2010
Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remissionSatoshi Nishiwaki, Yoshihiro Inamoto, Hisashi Sakamaki, et al.Pageof 16